Kobayashi Junji, Miyashita Kazuya, Nakajima Katsuyuki, Mabuchi Hiroshi
Kanazawa Medical University General Internal Medicine.
J Atheroscler Thromb. 2015;22(10):1001-11. doi: 10.5551/jat.31617. Epub 2015 Jul 21.
Hepatic lipase (HL) is a key enzyme catalyzing the hydrolysis of triglycerides (TG) and phospholipids (PLs) in several lipoproteins. It is generally recognized that HL is involved in the remodeling of remnant, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and the production of small, dense low-density lipoproteins (sd-LDLs).On the other hand, it is unclear whether HL accelerates or retards atherosclerosis. From the clinical point of view, HL deficiency may provide useful information on answering this question, but the rarity of this disease makes it impossible to conduct epidemiological study.In this review, we describe a comprehensive and updated view of the clinical significance of HL on lipid and lipoprotein metabolism.
肝脂酶(HL)是一种催化多种脂蛋白中甘油三酯(TG)和磷脂(PL)水解的关键酶。人们普遍认为,HL参与残余脂蛋白、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)的重塑以及小而密低密度脂蛋白(sd-LDL)的产生。另一方面,HL是加速还是延缓动脉粥样硬化尚不清楚。从临床角度来看,HL缺乏可能为回答这个问题提供有用信息,但这种疾病的罕见性使得无法进行流行病学研究。在这篇综述中,我们描述了HL在脂质和脂蛋白代谢方面临床意义的全面且最新的观点。